RxDoctor Payments Data

Christie Dipietrantonio, NP

Nurse Practitioner · New York, NYNPI 1356116362

Payments from drug & device makers

$1,477in general payments, 2019–2025

Across 30 payments — averaging $49.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$333
  • Lilly USA, LLC$232
  • Sun Pharmaceutical Industries Inc.$191
  • Johnson & Johnson$190
  • Incyte Corporation$179
  • Botanix SB Inc$127
  • plus $226 from 4 others

What the payments were for

  • Food & beverage$1,37793%
  • Education$1007%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.2$333
Lilly USA, LLC7$232
Sun Pharmaceutical Industries Inc.6$191
Johnson & Johnson7$190
Incyte Corporation3$179
Botanix SB Inc1$127
Novartis1$116
Biowound Solutions, Inc.1$48
Cipher Pharmaceuticals US LLC1$40
UCB, Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,477 in reported general payments places this provider in the 90th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Medicare billing

Part B allowed, 2024
$3,188
Medicare patients
21
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate24$228
Fluticasone Propionate12$133
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$117
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$40
Prednisone13$18

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →